PROGESTIA®, is a powerful vitamin and mineral rich prenatal supplement that combines the proven all-natural power of signature micronutrients in combination with fast absorbing fatty acids to deliver enhanced nourishment for women during pregnancy and preconception. Numerous clinical and scientific studies have cemented findings that demonstrate the advantage that women have when taking fatty acids in combination with prenatal vitamin and mineral regiments.
PROGESTIA® is based upon past, present and ongoing scientific, clinical and medical studies, literature and tests that purport the efficacy of its constituents. According to numerous studies, fatty acids are important for the development of the fetal and neonatal brain as well as helping to decrease the risk of low birth weight, defects and premature birth. All the ingredients that compose PROGESTIA® are certified kosher and halal.
We advise that all users first speak with their doctor before using this or any other natural supplement. Only your primary care physician can offer you medical advice that pertains specifically to your unique situation. This supplement is not intended to diagnose, treat, cure or prevent any diseases, illnesses or ailments.
Approved by Health Canada. NPN: 80037185
Recommended Dose: 1 softgel per Day
- Vitamin A (Acetate) : 5000 IU
- Vitamin D3 : 1000 IU (25 mcg)
- Vitamin E (tocopherol) : 50 IU
- Iron (fumarate) : 45 mg
- Zinc (gluconate) : 15 mg
- Copper (chelate pvh) : 2 mg
- Iodine (potassium) : 150 mcg
- Folic acid : 1 mg
- Vitamin B6 : 10 mg
- Vitamin B12 (methylcobalamine) : 12 mcg
- Fatty acids (fish oil)
- DHA (Decosahexaenoic acid) : 300 mg
- EPA (Eicosapentaenoic acid) : 70 mg
- Bailey RL, West KP, Jr., & Black RE (2015) The epidemiology of global micronutrient deficiencies. Ann Nutr Metab 66 Suppl 2:22-33.
- Clagett-Dame M & Knutson D (2011) Vitamin A in reproduction and development. Nutrients 3(4):385-428.
- Goh YI, Bollano E, Einarson TR, & Koren G (2006) Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can 28(8):680-689.
- Dror DK & Allen LH (2012) Interventions with vitamins B6, B12 and C in pregnancy. Paediatr Perinat Epidemiol 26 Suppl 1:55-74.
- Rodriguez-Dehli AC, et al. (2015) [Prevalence of vitamin d deficiency and insuffiency and associated factors in pregnant women of northern Spain]. Nutr Hosp 31(4):1633-1640.
- Aghajafari F, et al. (2013) Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ 346:f1169.
- Gagne A, Wei SQ, Fraser WD, & Julien P (2009) Absorption, transport, and bioavailability of vitamin e and its role in pregnant women. J Obstet Gynaecol Can 31(3):210-217.
- Zingg JM, Meydani M, & Azzi A (2012) alpha-Tocopheryl phosphate–an activated form of vitamin E important for angiogenesis and vasculogenesis? Biofactors 38(1):24-33.
- Rumbold AR, et al. (2006) Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 354(17):1796-1806.
- Yanik FF, Amanvermez R, Yanik A, Celik C, & Kokcu A (1999) Pre-eclampsia associated with increased lipid peroxidation and decreased serum vitamin E levels. Int J Gynaecol Obstet 64(1):27-33.
- Traber MG (2014) Vitamin E inadequacy in humans: causes and consequences. Adv Nutr 5(5):503-514.
- Hovdenak N & Haram K (2012) Influence of mineral and vitamin supplements on pregnancy outcome. Eur J Obstet Gynecol Reprod Biol 164(2):127-132.
- Granfors M, et al. (2015) Iodine deficiency in a study population of pregnant women in Sweden. Acta Obstet Gynecol Scand.
- Markhus MW, et al. (2015) Docosahexaenoic Acid Status in Pregnancy Determines the Maternal Docosahexaenoic Acid Status 3-, 6- and 12 Months Postpartum. Results from a Longitudinal Observational Study. PLoS One 10(9):e0136409.
- Bobinski R & Mikulska M (2015) The ins and outs of maternal-fetal fatty acid metabolism. Acta Biochim Pol.